EMA, FDA Accept Filing for BI’s Biosimilar to Humira
By

By
Both the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have accepted for review Boehringer Ingelheim’s (BI) adalimumab biosimilar candidate to AbbVie’s Humira (adalimumab), designated as…

Valeant To Sell Dendreon Pharmaceuticals to China’s Sanpower for $820 Million
By

By
Valeant Pharmaceuticals has agreed to sell all of the outstanding equity interests in Dendreon Pharmaceuticals, headquartered in Seattle, Washington, to the Sanpower Group, a privately owned business conglomerate based in…

Pharma, Gates Foundation Form Global Vaccine Partnership CEPI
By

By
The Bill & Melinda Gates Foundation, the Wellcome Trust, and the governments of Germany, Japan, and Norway have pledged $460 million to the Coalition for Epidemic Preparedness Innovations (CEPI), a global private-public…

Generex to Acquire Orphan Drug Company in $225-Million Deal
By

By
Generex Biotechnology, based in Toronto, has signed a letter of intent to acquire a controlling equity interest in Emmaus Life Sciences, a Torrance, California-headquartered biopharmaceutical company specializing in therapeutics for…

Lilly to Cut 485 Sales Jobs Across US Operations
By

By
Eli Lilly and Company plans to cut 485 sales positions across its operations in the US, including its US Bio-Medicines Business Unit located in Indianapolis, Indiana, as the result of a…

Endo, FTC Agree to Settle Pain Med Litigation
By

By
Endo International, a specialty pharmaceutical and generic-drug company, and the US Federal Trade Commission (FTC) have filed a joint motion in federal court to resolve litigation surrounding two of Endo’s…

Lilly to Acquire Migraine Drug Company in $960-Million Deal
By

By
Eli Lilly and Company has agreed to acquire CoLucid Pharmaceuticals, a Cambridge, Massachusetts-based biopharmaceutical company focused on migraine therapies, for $46.50 per share or approximately $960 million in an all-cash…

GSK Names New Global Pharma President, as Current President Departs
By

By
GlaxoSmithKline (GSK) has appointed Luke Miels as the new president of its Global Pharmaceuticals business  with the upcoming departure of the current Global Pharmaceuticals president, Abbas Hussain. Mr. Hussain has…

GEA, Siemens Partner in Continuous Tableting
By

By
GEA, an equipment manufacturer, and Siemens AG, a provider of industrial and manufacturing systems,  have partnered to offer an integrated continuous tablet manufacturing line that comprises GEA’s ConsiGma continuous manufacturing…

AB BioTechnologies Adds Contract Manufacturing
By

By
AB BioTechnologies, a drug-development services company located in Bloomington, Indiana, has announced plans to add contract manufacturing operations in Bloomington, creating up to 33 new jobs by 2020. The company has…